Dihexa Reconstitution Chart (Every Vial Size)

Comprehensive Dihexa Reconstitution Reference Matrix

In cell culture models and enzymatic binding assays, maintaining precise molarity and mass concentration is critical for data integrity. The following reference table maps standardized lyophilized Dihexa vial masses against standard diluent addition volumes (such as bacteriostatic water, sterile water, or DMSO pre-solubilization mixtures). Use this matrix to quickly identify resulting concentrations (mg/mL) and nominal mass delivery per 0.1 mL (10 IU on a standard laboratory syringe).

| Vial Size (Mass) | Solvent Added (mL) | Resulting Concentration (mg/mL) | Mass Content per 0.1 mL | Mass Content per 0.05 mL | | :--- | :--- | :--- | :--- | :--- | | 5 mg | 1.0 mL | 5.00 mg/mL | 0.50 mg | 0.25 mg | | 5 mg | 2.0 mL | 2.50 mg/mL | 0.25 mg | 0.125 mg | | 5 mg | 5.0 mL | 1.00 mg/mL | 0.10 mg | 0.05 mg | | 10 mg | 1.0 mL | 10.00 mg/mL | 1.00 mg | 0.50 mg | | 10 mg | 2.0 mL | 5.00 mg/mL | 0.50 mg | 0.25 mg | | 10 mg | 4.0 mL | 2.50 mg/mL | 0.25 mg | 0.125 mg | | 10 mg | 5.0 mL | 2.00 mg/mL | 0.20 mg | 0.10 mg | | 20 mg | 2.0 mL | 10.00 mg/mL | 1.00 mg | 0.50 mg | | 20 mg | 4.0 mL | 5.00 mg/mL | 0.50 mg | 0.25 mg | | 20 mg | 5.0 mL | 4.00 mg/mL | 0.40 mg | 0.20 mg | | 50 mg | 5.0 mL | 10.00 mg/mL | 1.00 mg | 0.50 mg | | 50 mg | 10.0 mL | 5.00 mg/mL | 0.50 mg | 0.25 mg |

Researchers requiring custom volumes or non-standard vial masses beyond this reference table can utilize our automated interactive peptide reconstitution calculator to derive exact microgram-level working solutions. For solid assay formats, researchers may also evaluate standardized Dihexa capsules 10mg intended specifically for solid-state analytical protocols or controlled chemical characterization.

Mathematical Formulation & Step-by-Step Reconstitution Equations

To establish precise concentration values without relying solely on reference tables, bench researchers must apply fundamental volumetric concentration formulas. Reconstitution calculations determine the final target concentration based on the initial dry mass of the lyophilized target compound and the total volume of liquid introduced into the vial.

The primary equation for determining final working concentration (C) is defined as: $$C = \frac{M}{V}$$ where $C$ is the concentration in milligrams per milliliter (mg/mL), $M$ is the total mass of the active compound in milligrams (mg), and $V$ is the total solvent volume added in milliliters (mL).

To calculate the total mass present in a specific aliquot volume ($V_{aliquot}$), apply the secondary formula: $$M_{aliquot} = C \times V_{aliquot}$$ When utilizing 0.1 mL micro-aliquots for microplate dispensing, the delivered mass simplifies to $M_{0.1} = C \times 0.1$. Ensuring precise calibration of micropipettes or volumetric syringes prevents cumulative error in downstream assay replicates.

Worked Example 1: Reconstituting a 10 mg Dihexa Research Vial

Consider a laboratory protocol that calls for working with a 10 mg vial of high-purity Dihexa lyophilized powder to achieve a target concentration suitable for high-throughput screening assays.

Step 1: Identify the starting mass ($M = 10\text{ mg}$). Step 2: Determine target solvent addition ($V = 2.0\text{ mL}$ of laboratory-grade solvent). Step 3: Apply the primary equation: $C = 10\text{ mg} / 2.0\text{ mL} = 5.0\text{ mg/mL}$. Step 4: Calculate the mass per 0.1 mL aliquot: $M_{0.1} = 5.0\text{ mg/mL} \times 0.1\text{ mL} = 0.5\text{ mg}$ (or 500 micrograms).

This standard $5.0\text{ mg/mL}$ stock solution provides an accessible, stable concentration that can be easily diluted further into cell culture media or assay buffers.

Worked Example 2: Reconstituting a 20 mg Dihexa Research Vial

In larger experimental setups requiring higher overall active yield, a researcher may reconstitute a 20 mg vial of Dihexa using a total diluent volume of 4.0 mL.

Step 1: Identify starting mass ($M = 20\text{ mg}$). Step 2: Add $V = 4.0\text{ mL}$ of sterile diluent. Step 3: Calculate concentration: $C = 20\text{ mg} / 4.0\text{ mL} = 5.0\text{ mg/mL}$. Step 4: Verify aliquot mass yield: $M_{0.1} = 5.0\text{ mg/mL} \times 0.1\text{ mL} = 0.5\text{ mg}$.

Notice that while the total vial mass doubled compared to Example 1, doubling the solvent volume produced an identical final concentration of $5.0\text{ mg/mL}$, demonstrating how adjusting diluent volumes yields consistent target molarities across varying batch sizes.

Diluent Selection & Solubility Characteristics of Dihexa

Dihexa (N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide) is an oligopeptide derivative designed to bind hepatocyte growth factor (HGF) with high affinity in preclinical research models. Because of its specific lipophilic hexanoyl side chain and hydrophobic residues, its solubility profile differs from basic hydrophilic peptides.

While standard hydrophilic compounds dissolve readily in pure aqueous buffers, Dihexa exhibits optimal solubility in organic solvents such as dimethyl sulfoxide (DMSO) or ethanol prior to aqueous buffering. For aqueous experimental protocols, researchers frequently perform initial solubilization in a minimal volume of high-purity DMSO (e.g., 5-10% total final volume) before bringing the final solution to volume with sterile bacteriostatic water or phosphate-buffered saline (PBS).

In vitro data indicate that maintaining proper solvent composition prevents premature aggregation or precipitation out of solution. Researchers selecting reagents across our complete catalog of research peptides should consult the chemical specification sheets to determine whether organic co-solvents or aqueous diluents are recommended for their specific assay temperature and pH parameters. For detailed chemical properties, review our guide on peptide solubility principles.

Step-by-Step Laboratory Protocol for Aseptic Dihexa Reconstitution

To preserve peptide stability, maintain sterility, and eliminate potential cross-contamination during preparation, laboratory personnel should adhere to strict aseptic techniques within a certified laminar flow hood.

1. Disinfect the rubber stopper of the lyophilized Dihexa vial using a fresh 70% isopropyl alcohol wipe and allow it to air-dry completely. 2. Draw the predetermined volume of diluent (e.g., BAC water or pre-mixed DMSO/buffer solution) into a sterile lab-grade syringe. 3. Insert the needle through the center of the rubber stopper at a slight angle. Release the liquid slowly down the inner glass wall of the vial to minimize splashing and foaming. 4. Gently swirl the vial in a circular motion until the lyophilized powder is completely dissolved. Never shake the vial vigorously, as shear forces can disrupt peptide molecular structure. 5. Inspect the resulting solution under direct lighting to confirm complete clarity and the absence of undissolved particulate matter.

Comparative Analysis: Dihexa and Related Cognitive Research Compounds

Preclinical investigations into synaptogenesis and neuroplasticity pathways frequently evaluate Dihexa alongside other synthesized oligopeptides and small molecules. For instance, researchers studying memory formation models compare the HGF/c-Met receptor engagement of Dihexa with central nervous system compounds like Semax research protocols, Selank reconstitution workflows, and NSI-189.

While Semax and Selank act Primarily via melanocortin and GABAergic/neurotrophic signaling cascades in rodent models, Dihexa exhibits potent affinity for HGF, facilitating dimerization and downstream c-Met phosphorylation in vitro. Understanding these mechanistic differences allows laboratories to select the precise research peptide profile needed for their electrophysiological or cell culture assays.

Quality Verification: HPLC, MS, and Endotoxin Testing at PX1 Research

Analytical consistency is the cornerstone of reproducible scientific research. Every batch of Dihexa supplied by PX1 Research undergoes stringent laboratory verification in ISO 17025 accredited facilities prior to distribution.

Our quality control pipeline utilizes High-Performance Liquid Chromatography (HPLC) to verify chemical purity exceeding 99% and Mass Spectrometry (MS) to confirm exact molecular weight. Furthermore, every lot undergoes chromogenic LAL endotoxin testing to guarantee levels well below strict laboratory thresholds. Institutional buyers and academic investigators can view or download a lot-specific COA directly from our platform prior to conducting studies.

All PX1 products are USA-manufactured in GMP-compliant facilities and shipped directly from our primary distribution hubs in California and Arizona. Orders placed Monday through Friday ship same-day to minimize operational delays for active research laboratories. Laboratories interested in establishing institutional accounts or securing bulk volumes can explore our wholesale laboratory account options.

Storage, Stability, and Aliquoting Protocols for Reconstituted Dihexa Assays

Lyophilized Dihexa powder remains stable at -20°C for extended periods when kept protected from light and moisture. However, once reconstituted into liquid form, peptide degradation rates accelerate depending on solvent selection and storage temperature.

Reconstituted solutions stored at 2°C to 8°C should be utilized within short timeframes (typically 14 to 28 days depending on antibacterial preservation). For long-term storage of liquid stock solutions, prepare single-use aliquots using polypropylene microcentrifuge tubes and store them at -80°C. Avoid repeated freeze-thaw cycles, as thermal cycling causes molecular degradation and mechanical shearing.

For additional scientific background on maintaining peptide stability across varied experimental setups, browse the extensive resources in our PX1 research library.